SLE Focus Rheum| RA Focus Rheum| Rheum for Everyone, Episode 12

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Jason Liebowitz, MD

Jason Liebowitz, MD, is a rheumatologist with Skylands Medical Group in Rockaway, N.J. He completed his undergraduate studies at Johns Hopkins University, Baltimore, and was inducted into Phi Beta Kappa. He attended Johns Hopkins University School of Medicine and completed his internal medicine residency at Johns Hopkins Bayview Medical Center, where he also served as a chief resident. He completed his rheumatology fellowship at Johns Hopkins University and was nominated for the 2019 Distinguished Fellow Award from the American College of Rheumatology. His research has been published in JAMA Internal Medicine, The Journal of Rheumatology, Arthritis Care and Research, The American Journal of Medicine and Medical Humanities. He is a co-editor of the textbook, Clinical Innovation in Rheumatology: Past, Present, and Future, published in 2022. He greatly enjoys teaching trainees and caring for patients, which he considers a tremendous honor and privilege, and he is grateful to be able to cover medical conferences and contribute articles to The Rheumatologist.

Articles by Jason Liebowitz, MD

Helping Patients with SLE Thrive

  |  

Dr. Laurent Arnaud highlighted the latest information on systemic lupus erythematosus (SLE), including genetics, technology, treat to target, and promising findings for pulse therapy in his session at EULAR 2024.

What’s New in Polymyalgia Rheumatica?

  |  

Should all patients with polymyalgia rheumatica (PMR) have a vascular ultrasound assessment? What treatments are the safest and most efficacious for patients with PMR? Frank Buttgereit, MD, answered these questions and highlighted the latest research on PMR in this session at EULAR 2024.

CAR-T Cell Therapy in Autoimmune Disease: The Next Frontier

  |  

Chimeric antigen receptor (CAR) T cell therapy has the potential to fundamentally shift the treatment of autoimmune disease. During his presentation at EULAR 2024, Georg Schett, MD, provided an overview of this treatment process and described the promising findings of the latest research.

When Rheumatologists Have Rheumatic Diseases

  |  

  “I think we learn from medicine everywhere that it is, at its heart, a human endeavor, requiring good science but also a limitless curiosity and interest in your fellow human being, and that the physician-patient relationship is key; all else follows from it.”1 These profound words from Abraham Verghese, MD, MACP, Linda R. Meier…

Paul Plotz, MD

An Interview with Dr. Paul Plotz

  |  

Editor’s note: Jan. 23, 2024. We have just learned that Dr. Paul Plotz passed away recently following a long illness. Come back soon for additional information. Here, we republish an interview with Dr. Plotz from 2019.

An Interview with Expert Clinician Dr. Fred Wigley

  |  

Rheumatologists who are outstanding researchers, educators and/or clinicians, who provide consistently exceptional care to patients, who have achieved a level of  distinction in the field and who serve as role models for colleagues and trainees are highlighted in this recurring series. Fred Wigley, MD, MACR, is the Martha McCrory Professor of Medicine at the Johns…